The Intensive Hospital Monitoring for Adverse Drug Reactions of Yang-Xin-Shi Tablet

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-12002915

Enrollment

Unknown

Registered

2012-12-25

Start date

2011-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases on the label of Shenmai Injection

Interventions

Observed Group:Shenmai Injection

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: all the patients that used Shenmai Injection and accord with ethics requirements in the research centers

Exclusion criteria

Exclusion criteria: patients used Shenmai Injection not in accordance with the lable

Design outcomes

Primary

Measure	Time frame
Incidence of severe adverse drug reaction;	—

Secondary

Measure	Time frame
the incidence of adverse drug reaction;	—

Countries

China

Contacts

Public ContactZhong Wang

zhonw@vip.sina.com+86 10-64014411-3308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026